Cubist Systematic Strategies’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.12K | Buy |
+1,916
| New | +$4.12K | ﹤0.01% | 1424 |
|
|
2024
Q2 | – | Sell |
-8,483
| Closed | -$120K | – | 1400 |
|
|
2024
Q1 | $120K | Buy |
+8,483
| New | +$120K | ﹤0.01% | 1781 |
|
|
2023
Q4 | – | Sell |
-1,988
| Closed | -$29.8K | – | 2093 |
|
|
2023
Q3 | $29.8K | Sell |
1,988
-1,088
| -35% | -$16.3K | ﹤0.01% | 1742 |
|
|
2023
Q2 | $48.9K | Sell |
3,076
-75
| -2% | -$1.19K | ﹤0.01% | 1908 |
|
|
2023
Q1 | $22.6K | Buy |
+3,151
| New | +$22.6K | ﹤0.01% | 2620 |
|
|
2022
Q4 | – | Sell |
-1,438
| Closed | -$14K | – | 3233 |
|
|
2022
Q3 | $14K | Sell |
1,438
-293
| -17% | -$2.85K | ﹤0.01% | 3458 |
|
|
2022
Q2 | $21K | Buy |
1,731
+261
| +18% | +$3.17K | ﹤0.01% | 3672 |
|
|
2022
Q1 | $19K | Sell |
1,470
-5,142
| -78% | -$66.5K | ﹤0.01% | 3454 |
|
|
2021
Q4 | $116K | Buy |
6,612
+403
| +6% | +$7.07K | ﹤0.01% | 3168 |
|
|
2021
Q3 | $135K | Sell |
6,209
-2,087
| -25% | -$45.4K | ﹤0.01% | 2681 |
|
|
2021
Q2 | $290K | Buy |
8,296
+5,754
| +226% | +$201K | ﹤0.01% | 2354 |
|
|
2021
Q1 | $251K | Buy |
+2,542
| New | +$251K | ﹤0.01% | 2355 |
|
|
2020
Q4 | – | Sell |
-13,697
| Closed | -$1.41M | – | 2538 |
|
|
2020
Q3 | $1.41M | Buy |
+13,697
| New | +$1.41M | 0.02% | 1127 |
|
|
2020
Q2 | – | Sell |
-3,100
| Closed | -$303K | – | 2375 |
|
|
2020
Q1 | $303K | Sell |
3,100
-731
| -19% | -$71.4K | 0.01% | 1512 |
|
|
2019
Q4 | $441K | Buy |
+3,831
| New | +$441K | 0.01% | 1621 |
|
|
2019
Q1 | – | Sell |
-2,784
| Closed | -$88K | – | 2217 |
|
|
2018
Q4 | $88K | Buy |
+2,784
| New | +$88K | ﹤0.01% | 1782 |
|
|
2018
Q3 | – | Sell |
-1,353
| Closed | -$72K | – | 1842 |
|
|
2018
Q2 | $72K | Sell |
1,353
-3,172
| -70% | -$169K | ﹤0.01% | 1601 |
|
|
2018
Q1 | $262K | Buy |
+4,525
| New | +$262K | 0.02% | 1236 |
|